These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 25869895)
21. Implementation of Strategies to Improve Human Papillomavirus Vaccine Coverage: A Provider Survey. Walling EB; Dodd S; Bobenhouse N; Reis EC; Sterkel R; Garbutt J Am J Prev Med; 2019 Jan; 56(1):74-83. PubMed ID: 30573149 [TBL] [Abstract][Full Text] [Related]
22. Infrastructure requirements for human papillomavirus vaccination and cervical cancer screening in sub-Saharan Africa. Sankaranarayanan R; Anorlu R; Sangwa-Lugoma G; Denny LA Vaccine; 2013 Dec; 31 Suppl 5():F47-52. PubMed ID: 24331747 [TBL] [Abstract][Full Text] [Related]
23. Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Russian Federation, the Western countries of the former Soviet Union, Caucasus region and Central Asia. Rogovskaya SI; Shabalova IP; Mikheeva IV; Minkina GN; Podzolkova NM; Shipulina OY; Sultanov SN; Kosenko IA; Brotons M; Buttmann N; Dartell M; Arbyn M; Syrjänen S; Poljak M Vaccine; 2013 Dec; 31 Suppl 7():H46-58. PubMed ID: 24332297 [TBL] [Abstract][Full Text] [Related]
24. Factors impacting HPV vaccination: lessons for health care professionals. Hofstetter AM; Rosenthal SL Expert Rev Vaccines; 2014 Aug; 13(8):1013-26. PubMed ID: 24965128 [TBL] [Abstract][Full Text] [Related]
25. From non school-based, co-payment to school-based, free Human Papillomavirus vaccination in Flanders (Belgium): a retrospective cohort study describing vaccination coverage, age-specific coverage and socio-economic inequalities. Lefevere E; Theeten H; Hens N; De Smet F; Top G; Van Damme P Vaccine; 2015 Sep; 33(39):5188-95. PubMed ID: 26254978 [TBL] [Abstract][Full Text] [Related]
26. The school nurse, the school and HPV vaccination: a qualitative study of factors affecting HPV vaccine uptake. Brabin L; Stretch R; Roberts SA; Elton P; Baxter D; McCann R Vaccine; 2011 Apr; 29(17):3192-6. PubMed ID: 21354481 [TBL] [Abstract][Full Text] [Related]
27. Parental attitudes towards male human papillomavirus vaccination: a pan-European cross-sectional survey. Lee Mortensen G; Adam M; Idtaleb L BMC Public Health; 2015 Jul; 15():624. PubMed ID: 26152138 [TBL] [Abstract][Full Text] [Related]
28. Prophylactic human papillomavirus vaccination and primary prevention of cervical cancer: issues and challenges. Poljak M Clin Microbiol Infect; 2012 Oct; 18 Suppl 5():64-9. PubMed ID: 22862799 [TBL] [Abstract][Full Text] [Related]
29. Human papillomavirus vaccination recommendation may be linked to reimbursement: a survey of Virginia family practitioners and gynecologists. Young JL; Bernheim RG; Korte JE; Stoler MH; Guterbock TM; Rice LW J Pediatr Adolesc Gynecol; 2011 Dec; 24(6):380-5. PubMed ID: 21906978 [TBL] [Abstract][Full Text] [Related]
30. Sociodemographic factors predicting mother's cervical screening and daughter's HPV vaccination uptake. Spencer AM; Roberts SA; Brabin L; Patnick J; Verma A J Epidemiol Community Health; 2014 Jun; 68(6):571-7. PubMed ID: 24567443 [TBL] [Abstract][Full Text] [Related]
31. Association between mothers' screening uptake and daughters' HPV vaccination: a quasi-experimental study on the effect of an active invitation campaign. Venturelli F; Baldacchini F; Campari C; Perilli C; Pascucci MG; Finarelli AC; Moscara L; Rossi PG BMJ Open; 2017 Sep; 7(9):e016189. PubMed ID: 28951407 [TBL] [Abstract][Full Text] [Related]
32. Provider perceptions of barriers and facilitators of HPV vaccination in a high-risk community. Javanbakht M; Stahlman S; Walker S; Gottlieb S; Markowitz L; Liddon N; Plant A; Guerry S Vaccine; 2012 Jun; 30(30):4511-6. PubMed ID: 22561142 [TBL] [Abstract][Full Text] [Related]
33. Reported adverse events in girls aged 13-16 years after vaccination with the human papillomavirus (HPV)-16/18 vaccine in the Netherlands. van Klooster TM; Kemmeren JM; van der Maas NA; de Melker HE Vaccine; 2011 Jun; 29(28):4601-7. PubMed ID: 21549785 [TBL] [Abstract][Full Text] [Related]
34. Exploring variation in human papillomavirus vaccination uptake in Switzerland: a multilevel spatial analysis of a national vaccination coverage survey. Riesen M; Konstantinoudis G; Lang P; Low N; Hatz C; Maeusezahl M; Spaar A; Bühlmann M; Spycher BD; Althaus CL BMJ Open; 2018 May; 8(5):e021006. PubMed ID: 29773702 [TBL] [Abstract][Full Text] [Related]
35. Parental acceptance of human papillomavirus (HPV) vaccination in Indonesia: a cross-sectional study. Jaspers L; Budiningsih S; Wolterbeek R; Henderson FC; Peters AA Vaccine; 2011 Oct; 29(44):7785-93. PubMed ID: 21821079 [TBL] [Abstract][Full Text] [Related]
36. Human papillomavirus vaccine in adolescent women: a 2012 update. Etter DJ; Zimet GD; Rickert VI Curr Opin Obstet Gynecol; 2012 Oct; 24(5):305-10. PubMed ID: 22781077 [TBL] [Abstract][Full Text] [Related]
37. Primary care pediatricians' attitudes and practice towards HPV vaccination: A nationwide survey in Italy. Napolitano F; Navaro M; Vezzosi L; Santagati G; Angelillo IF PLoS One; 2018; 13(3):e0194920. PubMed ID: 29596515 [TBL] [Abstract][Full Text] [Related]
38. Challenges in cervical cancer prevention: a survey of U.S. obstetrician-gynecologists. Perkins RB; Anderson BL; Gorin SS; Schulkin JA Am J Prev Med; 2013 Aug; 45(2):175-81. PubMed ID: 23867024 [TBL] [Abstract][Full Text] [Related]
39. Acceptability and uptake of HPV vaccine in Argentina before its inclusion in the immunization program: a population-based survey. Arrossi S; Maceira V; Paolino M; Sankaranarayanan R Vaccine; 2012 Mar; 30(14):2467-74. PubMed ID: 22266289 [TBL] [Abstract][Full Text] [Related]
40. Adolescents' awareness of HPV infections and attitudes towards HPV vaccination 3 years following the introduction of the HPV vaccine in Hungary. Marek E; Dergez T; Rebek-Nagy G; Kricskovics A; Kovacs K; Bozsa S; Kiss I; Ember I; Gocze P Vaccine; 2011 Nov; 29(47):8591-8. PubMed ID: 21939711 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]